Navigation Links
BioMarin Announces Third Quarter 2009 Financial Results
Date:10/28/2009

. The March 2013 notes reflecting 10.4 million shares are excluded from the non-GAAP diluted earnings per share for the 2009 periods presented as their impact is considered anti-dilutive.

Conference Call Details

BioMarin will host a conference call and webcast to discuss third quarter 2009 financial results today, Wednesday, October 28, at 5:00 p.m. ET. This event can be accessed on the investor section of the BioMarin website at www.BMRN.com.

    Date: October 28, 2009
    Time: 5:00 p.m. ET
    U.S. / Canada Dial-in Number:  800.299.6183
    International Dial-in Number:  617.801.9713
    Participant Code: 51404008
    Replay Dial-in Number: 888.286.8010
    Replay International Dial-in Number: 617.801.6888
    Replay Code: 51416825

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of MPS IVA. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. BioMarin to Present at the Oppenheimer Healthcare Conference
2. BioMarin Acquires Huxley Pharmaceuticals, Inc.
3. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
4. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
5. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
6. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
7. BioMarin Announces FDA Approval for Kuvan
8. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
9. Rigel Announces Presentations at Two Investor Conferences
10. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
11. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Zynerba Pharmaceuticals , Inc., a specialty ... synthetic cannabinoid treatments, today announced that the company will ... 2014. The conference will be held December 2 to ... New York . Zynerba,s Chairman and CEO, ... Tuesday, December 2. To listen to a ...
(Date:11/26/2014)... Nov. 26, 2014  Aridis Pharmaceuticals, Inc., a ... therapies for infectious diseases, announced today the addition ... recognized key opinion leader in the areas of ... board. Founder and Chief Executive Officer, ... Dr. Opal,s extensive experience investigating bacterial toxins and ...
(Date:11/26/2014)... and NEW YORK ... As the leading distributor of market intelligence, ... new research report by IQ4I Research and Consultancy focusing ... To learn more about IQ4I Research visit: ... Active Pharmaceutical Ingredients Global Market – Forecast to ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3
... Beginning today, Northside Hospital and Atlanta Perinatal Consultants announce ... test for common fetal trisomies, such as trisomy 21 ... Edwards syndrome. The Harmony Prenatal Test, ... testing platform to analyze DNA in maternal blood so ...
... 26, 2012 Quest International, Inc., a leading global ... solutions, announced today that is has contributed $5000 to ... the American Cancer Society Key Gala, that benefits the ... Massachusetts on Thursday, March 29, 2012. "We ...
Cached Medicine Technology:Northside Hospital and Atlanta Perinatal Consultants Partner to Offer Advanced, Non-Invasive Test for Prenatal Detection of Common Trisomies 2Northside Hospital and Atlanta Perinatal Consultants Partner to Offer Advanced, Non-Invasive Test for Prenatal Detection of Common Trisomies 3Quest International Donates $5000 to the American Cancer Society 2
(Date:11/28/2014)... Miami, FL (PRWEB) November 28, 2014 ... contemporary, responsive website. Practice founder Dr. Jeffrey ... site. Created using a groundbreaking WordPress platform, the ... devices. , Currently, up to 75% of ... More than ever, these people are logging on with ...
(Date:11/28/2014)... (HealthDay News) -- Celebration can quickly turn to ... Day, experts say. Over the last decade, more ... while people were using turkey fryers, according to the ... cared for a patient who tried to deep fry ... in any circumstances," Dr. Arthur Sanford, a burn surgeon ...
(Date:11/28/2014)... An inventor and dental assistant from Kent, Wash., was using ... was almost impossible to reach. "This gave me the idea ... patent-pending Access Light allows for easier use of a dental ... as well as avoids harm to the lips, tongue and ... clean, it also helps prevent cross-contamination. , The original design ...
(Date:11/28/2014)... 28, 2014 UniWigs.com, a leader in the wig ... Friday to the next Monday. This promotion features: , ... 40 items up to 70% off (no coupon code needed), ... > Free shipping on orders over $49 , Visit http://www.uniwigs.com ... days from Nov. 28th to Dec. 1st and the first 100 ...
(Date:11/28/2014)... Schools like Centra Rivermont understand the therapeutic and ... to its students. That is why the Virginia ... structure at its mental health services facility in ... for children who are identified as needing additional ... served the needs of children with severe emotional ...
Breaking Medicine News(10 mins):Health News:Top Rhinoplasty Surgeon Launches Innovative Website 2Health News:Turkey Fryer Mishaps Can Cause Serious Burns 2Health News:Pre-X'mas Crazy Sale Starts from $0 at UniWigs.com 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 2Health News:Centra Rivermont (VA) Provides School Playground Equipment from APCPLAY© for Special Needs Students 3
... a national single-payer style healthcare reform system would provide ... 2.6 million new jobs, and infusing $317 billion in ... in wages into the U.S. economy, according to the ... be viewed at www.CalNurses.org . The number ...
... The pharmaceutical industry is currently facing some ... costs, a decrease in the number of ... authorities are forcing companies to look at ... also demanding more effective and safer drugs.(Logo: ...
... Dental Studio (ORA) opened its second location at a renovated space in ... ... Dental Studio (ORA) opened its second location at a renovated space ... will introduce a fresh, progressive approach to general, aesthetic, and oral surgery ...
... presents an audio-slide presentation on the Diabetes Best Practices Website, analyzing ... control in treating type 2 diabetes as well as preventing heart ... ... -- Effectively and safely achieving glycemic goal has long been considered ...
... Peanut Corporation of America (PCA), a peanut processing ... to institutions, food service industries, and private label food ... produced in its Blakely, Georgia processing facility because it ... All product affected was produced on or after July ...
... Former Commissioner of the Food and Drug Administration Finds ... 13 On April 27, 2009 Rodale will publish "The ... by Dr. David A. Kessler who served as commissioner of ... and Bill Clinton. Over the course of seven ...
Cached Medicine News:Health News:First-of-Its Kind Study: Medicare for All (Single-Payer) Reform Would Be Major Stimulus for Economy With 2.6 Million New Jobs, $317 Billion in Business Revenue, $100 Billion in Wages 2Health News:First-of-Its Kind Study: Medicare for All (Single-Payer) Reform Would Be Major Stimulus for Economy With 2.6 Million New Jobs, $317 Billion in Business Revenue, $100 Billion in Wages 3Health News:First-of-Its Kind Study: Medicare for All (Single-Payer) Reform Would Be Major Stimulus for Economy With 2.6 Million New Jobs, $317 Billion in Business Revenue, $100 Billion in Wages 4Health News:Personalised Medicine: An Opportunity for Investment 2Health News:Personalised Medicine: An Opportunity for Investment 3Health News:Chicago's First Eco-friendly, Green Luxury Dental Practice - ORA Dental Studio - is Finally Here 2Health News:Diabetes and Cardiovascular Disease: Online Presentation Looks at the Complex Relationship of These Two Diseases in Light of Recent Studies 2Health News:Peanut Corporation of America Announces Voluntary Nationwide Recall of Peanut Butter 2Health News:Peanut Corporation of America Announces Voluntary Nationwide Recall of Peanut Butter 3Health News:Rodale to Publish Dr. David A. Kessler 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: